Background: The abnormal expression and prognosis prediction of epithelial cell transforming sequence 2 (ECT2) in gastric cancer (GC) has been reported. However, the effect of ECT2 on 5-fluorouracil (5-Fu) resistance in GC is unclear. This research aims to solve the abovementioned problems.
Methods: Gene expression was detected by RT-qPCR and Western blot analysis. Cell viability was evaluated by the colony formation assay, MTT assay, and flow cytometric analysis. Transwell and wound healing assays were used to detect cell metastasis.
Results: Upregulation of ECT2 was found in stomach adenocarcinoma (STAD) and GC tissues. In addition, high ECT2 expression can predict adverse clinical outcomes in GC patients. More importantly, ECT2 knockdown weakened the resistance of 5-FU in GC cells. ECT2 silencing reduced the cell migratory and invasive abilities of GC cells treated with 5-FU. We also found that downregulation of ECT2 increased 5-FU sensitivity in GC cells by downregulating P-gp, MRP1, and Bcl-2.
Conclusion: Upregulation of ECT2 can predict adverse clinical outcomes and increase 5-FU resistance in GC patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337122 | PMC |
| http://dx.doi.org/10.1155/2021/2102890 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Contribution of ECT2 to Tubulointerstitial Fibrosis in the Progression of Chronic Kidney Disease.
Curr Med Sci
December 2024
Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Objective: Chronic kidney disease (CKD) is a complex disorder resulting from a combination of various environmental and genetic factors. Considerable efforts have been dedicated to elucidating its etiological mechanisms. Nevertheless, the pathogenic mechanism of CKD remains poorly understood, which hinders the development of effective therapeutic strategies.
View Article and Find Full Text PDFTranscription factor ETS1‑mediated ECT2 expression promotes the malignant behavior of prostate cancer cells.
Oncol Lett
October 2024
Department of Urology, The Fifth Hospital of Xiamen City, Xiamen, Fujian 361101, P.R. China.
Prostate cancer remains the most prevalent malignancy diagnosed in men worldwide. Epithelial cell transforming sequence 2 (ECT2) is an oncogene involved in the progression of human tumors. The present study aimed to explore the involvement of ECT2 in prostate cancer and its participation in the malignant progression of prostate cancer.
View Article and Find Full Text PDFElevated expression of ECT2 as a diagnostic marker and prognostic indicator in endometrial cancer.
Gene
November 2024
Department of Gynaecology and Obstetrics, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China. Electronic address:
Objectives: The study aims to investigate genes associated with endometrial cancer (EC) progression to identify new biomarkers for early detection.
Methods: Differentially expressed genes (DEGs), Series test of cluster (STC) and protein-protein interaction analyses identified hub genes in EC. Clinical samples were utilized to examine the expression pattern of ECT2, assess its prognostic value, and evaluate its diagnostic potential.
Discovery and validation of combined biomarkers for the diagnosis of esophageal intraepithelial neoplasia and esophageal squamous cell carcinoma.
J Proteomics
July 2024
Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute of Oncologic Pathology, Cancer Research Center, Shantou University Medical College, Shantou, Guangdong 515041, China. Electronic address:
Early diagnosis and intervention of esophageal squamous cell carcinoma (ESCC) can improve the prognosis. The purpose of this study was to identify biomarkers for ESCC and esophageal precancerous lesions (intraepithelial neoplasia, IEN). Based on the proteomic and genomic data of esophageal tissue including previously reported data, up-regulated proteins with copy number amplification in esophageal cancer were screened as candidate biomarkers.
View Article and Find Full Text PDFGINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas.
Cell Death Dis
March 2024
The Key Laboratory of Model Animal and Stem Cell Biology in Hunan Province, Hunan Normal University, Changsha, 410013, Hunan, China.
Article Synopsis
- Temozolomide (TMZ) is a key treatment for glioma, a common brain cancer, but some patients don't respond well due to the cancer cells' strong DNA damage response (DDR).
- GINS2, a protein involved in DNA repair, was found to be increased in glioma cells after TMZ treatment and plays a role in their DNA damage response by influencing the stability of certain mRNA.
- Researchers developed a prognostic model involving GINS2, EGR1, and ECT2 that can predict patient survival and identified that a combined treatment with Palbociclib/BIX-02189 and TMZ could enhance the effectiveness against glioma by lowering GINS2 levels.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!